跳至主要内容
临床试验/NCT05946837
NCT05946837已完成1 期

Near-infrared Fluorescence Lymphatic Imaging Assessment of Lymphatic Response to Pneumatic Back/Neck Lymphatic Drainage Delivered by a Pneumatic Manual Lymphatic Drainage Device

The University of Texas Health Science Center, Houston1 个研究点 分布在 1 个国家目标入组 4 人开始时间: 2023年8月29日最近更新:
适应症
干预措施

试验速览

阶段
1 期
状态
已完成
入组人数
4
试验地点
1
主要终点
Change in frequency of lymphatic pulsing as assessed by the number of lymphatic pulses per minute in each region imaged

研究概览

简要总结

The purpose of this study is to objectively assess lymphatic function before, during, and immediately after Neuroglide treatment in lower trunk and leg lymphatic vessels, torso, axillary regions, inguinal regions, upper extremities, and cervical/neck and to determine any VAS (Visual Analog Scale, a commonly used measure of pain perception) score change after Neuroglide treatment.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ambulatory and possess all four limbs
  • Female participants of childbearing potential must have a negative urine pregnancy test within 36 hours prior to study drug administration
  • Female participants of childbearing potential must agree to use a medically accepted method of contraception for a period of one month following each imaging session in the study
  • Weight less than 400 lbs

排除标准

  • Women who are pregnant or breast-feeding
  • Persons who are allergic to iodine or indocyanine green
  • Heart failure, poorly controlled kidney disease (glomerular filtration rate <30 mls per minute), hypoproteinemia, pulmonary hypertension, or hypothyroidism
  • Any circumstance where increased lymphatic or venous return is undesirable

研究组 & 干预措施

Pneumatic Compression Therapy (PCT)

Experimental

干预措施: Indocyanine green (ICG) dye (Drug)

Pneumatic Compression Therapy (PCT)

Experimental

干预措施: NIRF-LI imaging (Device)

Pneumatic Compression Therapy (PCT)

Experimental

干预措施: Neuroglide pad (Device)

结局指标

主要结局

Change in frequency of lymphatic pulsing as assessed by the number of lymphatic pulses per minute in each region imaged

时间窗: Baseline, during Neuroglide treatment ( 1 hour after NIRF-LI imaging ), 1 hour after PCT treatment

次要结局

  • Change in pain as assessed by the Visual Analog Scale (VAS)(Baseline, 1 hour after PCT treatment, 4-8 weeks after imaging for data analysis completion)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Melissa B Aldrich

Associate Professor

The University of Texas Health Science Center, Houston

研究点 (1)

Loading locations...

相似试验